Patents by Inventor Kimberly O. Cameron

Kimberly O. Cameron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EP4 receptor selective agonists in the treatment of osteoporosis
    Publication number: 20020065308
    Abstract: This invention is directed to EP4 receptor selective prostaglandin agonists of the Formula I, 1
    Type: Application
    Filed: November 21, 2001
    Publication date: May 30, 2002
    Inventors: Kimberly O. Cameron, Bruce A. Lefker
  • Osteoporosis compounds
    Patent number: 6376502
    Abstract: This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
    Type: Grant
    Filed: February 22, 2000
    Date of Patent: April 23, 2002
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Bruce A. Lefker, Robert L. Rosati
  • EP4 receptor selective agonists in the treatment of osteoporosis
    Publication number: 20020040149
    Abstract: This invention is directed to methods of treating conditions which present with low bone mass, particularly osteoporosis, frailty, an osteoporotic fracture, a bone defect, childhood idiopathic bone loss, alveolar bone loss, mandibular bone loss, bone fracture, osteotomy, bone loss associated with periodontitis, or prosthetic ingrowth comprising administering prostaglandin agonists which are EP4 receptor selective prostaglandin agonists.
    Type: Application
    Filed: November 16, 2001
    Publication date: April 4, 2002
    Inventors: Kimberly O. Cameron, HuaZhu Ke, Bruce A. Lefker, David D. Thompson
  • Prevention of loss and restoration of bone mass by certain prostaglandin agonists
    Publication number: 20020016368
    Abstract: Prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
    Type: Application
    Filed: June 29, 2001
    Publication date: February 7, 2002
    Inventors: Kimberly O. Cameron, Hua Z. Ke, Bruce A. Lefker, Robert L. Rosati, David D. Thompson
  • Method for treating glaucoma
    Patent number: 6344485
    Abstract: Methods of using prostaglandin agonists for the reduction of intraocular pressure, and accordingly glaucoma.
    Type: Grant
    Filed: June 18, 1999
    Date of Patent: February 5, 2002
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Bruce A. Lefker
  • Treatment of osteoporsis with EP2/EP4 receptor selective agonists
    Publication number: 20010056060
    Abstract: This invention is directed to methods and pharmaceutical compositions comprising prostaglandin agonists which are userful to prevent bone loss, restore or augment bone mass and to enhance bone healing including the treatment of conditions which present with low bone mass, such as osteoporosis, and/or bone defects in vertebrates, and particularly mammals, including humans. This invention specifically relates to methods and pharmaceutical compositions comprising combinations of EP2 receptor selective agonists and EP4 receptor selective agonists and to methods and pharmaceutical compositions comprising agents which are agonists for both the EP2 receptor and the EP4 receptor.
    Type: Application
    Filed: February 2, 2001
    Publication date: December 27, 2001
    Inventors: Kimberly O. Cameron, HuaZhu Ke, Bruce A. Lefker, David D. Thompson
  • EP4 receptor selective agonists in the treatment of osteoporosis
    Publication number: 20010047105
    Abstract: This invention is directed to methods of treating conditions which present with low bone mass, particularly osteoporosis, frailty, an osteoporotic fracture, a bone defect, childhood idiopathic bone loss, alveolar bone loss, mandibular bone loss, bone fracture, osteotomy, bone loss associated with periodontitis, or prosthetic ingrowth comprising administering prostaglandin agonists which are EP4 receptor selective prostaglandin agonists.
    Type: Application
    Filed: December 15, 2000
    Publication date: November 29, 2001
    Inventors: Kimberly O. Cameron, HuaZhu Ke, Bruce A. Lefker, David D. Thompson
  • Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
    Publication number: 20010039285
    Abstract: This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits comprising such compounds.
    Type: Application
    Filed: December 21, 2000
    Publication date: November 8, 2001
    Inventors: Kimberly O. Cameron, Richard Chesworth, Paul A. DaSilva-Jardine, Robert F. Day, Bruce A. Lefker, Michael P. Zawistoski
  • Estrogen agonists/antagonists for preventing breast cancer
    Publication number: 20010025051
    Abstract: Compounds of this formula 1
    Type: Application
    Filed: March 28, 2001
    Publication date: September 27, 2001
    Inventors: Kimberly O. Cameron, Paul A. Dasilva-Jardine, Hua Zhu Ke, Robert L. Rosati
  • Prevention of loss and restoration of bone mass by certain prostaglandin agonists
    Patent number: 6288120
    Abstract: Prostaglandin agonists of formula (I), in which, for example, A is a sulphonyl or acyl group, B is N or CH, M contains a ring and K and Q are linking groups, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits useful for the treatment of bone disorders including osteoporosis.
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: September 11, 2001
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Hua Z. Ke, Bruce A. Lefker, Robert L. Rosati, David D. Thompson
  • Estrogen agonists/antagonists
    Patent number: 6204286
    Abstract: Compounds of the formula: are disclosed useful for treating osteoporosis, obesity, breast cancer, endometriosis, cardiovascular disease and prostatic disease. Substituents A, B, E, D, Z1, G, Y and e have the same meaning as defined in the specification.
    Type: Grant
    Filed: June 30, 1997
    Date of Patent: March 20, 2001
    Assignee: Pfizer Inc
    Inventors: Kimberly O. Cameron, Paul A. DaSilva Jardine, Robert L. Rosati
  • Estrogen agonists/antagonists
    Patent number: 6153622
    Abstract: Compounds of this formula ##STR1## are useful for treating or preventing, obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease.
    Type: Grant
    Filed: August 28, 1998
    Date of Patent: November 28, 2000
    Assignee: Pfizer, Inc.
    Inventors: Kimberly O. Cameron, Paul A. Dasilva-Jardine, Hua Zhu Ke, Robert L. Rosati
  • Osteoporosis compounds
    Patent number: 6124314
    Abstract: This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
    Type: Grant
    Filed: September 28, 1998
    Date of Patent: September 26, 2000
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Bruce A. Lefker, Robert L. Rosati
  • Bone deposition by certain prostaglandin agonists
    Patent number: 5703108
    Abstract: Methods for the treatment of bone disorders utilizing certain prostaglandin agonists/antagonists.
    Type: Grant
    Filed: February 20, 1997
    Date of Patent: December 30, 1997
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Paul A. Dasilva-Jardine, Robert L. Rosati
  • 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
    Patent number: 5552412
    Abstract: Compounds of this formula ##STR1## are useful for treating or preventing, obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease.
    Type: Grant
    Filed: January 9, 1995
    Date of Patent: September 3, 1996
    Assignee: Pfizer Inc
    Inventors: Kimberly O. Cameron, Paul A. Dasilva Jardine, Robert L. Rosati